The long run impact of early childhood deworming on numeracy and literacy: Evidence from Uganda.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
01 2019
Historique:
received: 01 05 2018
accepted: 17 12 2018
revised: 15 02 2019
pubmed: 1 2 2019
medline: 24 4 2019
entrez: 1 2 2019
Statut: epublish

Résumé

Up to 1.45 billion people currently suffer from soil transmitted helminth infection, with the largest burden occurring in Africa and Asia. Safe and cost effective deworming treatment exists, but there is a debate about mass distribution of this treatment in high prevalence settings. While the World Health Organization recommends mass administration of anthelmintic drugs for preschool and school-aged children in high (>20%) prevalence settings, and several long run follow up studies of an influential trial have suggested large benefits that persist over time, recent systematic reviews have called this recommendation into question. This paper analyzes the long-term impact of a cluster-randomized trial in eastern Uganda that provided mass deworming treatment to preschool aged children from 2000 to 2003 on the numeracy and literacy skills of children and young adults living in those villages in 2010-2015. This study uses numeracy and literacy data collected seven to twelve years after the end of the deworming trial in a randomly selected subset of communities from the original trial, by an education-focused survey that had no relationship to the deworming study. Building on an earlier working paper which used data from 2010 and 2011 survey rounds, this paper uses an additional four years of numeracy and literacy data (2012, 2013, 2014, and 2015). Aggregating data from all survey rounds, the difference between numeracy scores in treatment versus control communities is 0.07 standard deviations (SD) (95% CI -0.10, 0.24, p = 0.40), the difference in literacy scores is 0.05 SD (95% CI -0.16, 0.27, p = 0.62), and the difference in total scores is 0.07 SD (95% CI -0.11, 0.25, p = 0.44). There are significant differences in program impact by gender, with numeracy and literacy differentially positively affected for girls, and by age, with treatment effects larger for the primary school aged subsample. There are also significant treatment interactions for those living in households with more treatment-eligible children. There is no evidence of differential treatment effects on age at program eligibility or number of years of program eligibility. Mass deworming of preschool aged children in high prevalence communities in Uganda resulted in no statistically significant gains in numeracy or literacy 7-12 years after program completion. Point estimates were positive but imprecise; the study lacked sufficient power to rule out substantial positive effects or more modest negative effects. However, there is suggestive evidence that deworming was relatively more beneficial for girls, primary school aged children, and children living in households with other treated children. As this analysis was conducted on secondary data which is publicly available, no research approval was sought or received. All individual records were anonymized by the data provider prior to public release.

Sections du résumé

BACKGROUND
Up to 1.45 billion people currently suffer from soil transmitted helminth infection, with the largest burden occurring in Africa and Asia. Safe and cost effective deworming treatment exists, but there is a debate about mass distribution of this treatment in high prevalence settings. While the World Health Organization recommends mass administration of anthelmintic drugs for preschool and school-aged children in high (>20%) prevalence settings, and several long run follow up studies of an influential trial have suggested large benefits that persist over time, recent systematic reviews have called this recommendation into question.
METHODS AND FINDINGS
This paper analyzes the long-term impact of a cluster-randomized trial in eastern Uganda that provided mass deworming treatment to preschool aged children from 2000 to 2003 on the numeracy and literacy skills of children and young adults living in those villages in 2010-2015. This study uses numeracy and literacy data collected seven to twelve years after the end of the deworming trial in a randomly selected subset of communities from the original trial, by an education-focused survey that had no relationship to the deworming study. Building on an earlier working paper which used data from 2010 and 2011 survey rounds, this paper uses an additional four years of numeracy and literacy data (2012, 2013, 2014, and 2015). Aggregating data from all survey rounds, the difference between numeracy scores in treatment versus control communities is 0.07 standard deviations (SD) (95% CI -0.10, 0.24, p = 0.40), the difference in literacy scores is 0.05 SD (95% CI -0.16, 0.27, p = 0.62), and the difference in total scores is 0.07 SD (95% CI -0.11, 0.25, p = 0.44). There are significant differences in program impact by gender, with numeracy and literacy differentially positively affected for girls, and by age, with treatment effects larger for the primary school aged subsample. There are also significant treatment interactions for those living in households with more treatment-eligible children. There is no evidence of differential treatment effects on age at program eligibility or number of years of program eligibility.
CONCLUSIONS
Mass deworming of preschool aged children in high prevalence communities in Uganda resulted in no statistically significant gains in numeracy or literacy 7-12 years after program completion. Point estimates were positive but imprecise; the study lacked sufficient power to rule out substantial positive effects or more modest negative effects. However, there is suggestive evidence that deworming was relatively more beneficial for girls, primary school aged children, and children living in households with other treated children.
RESEARCH APPROVAL
As this analysis was conducted on secondary data which is publicly available, no research approval was sought or received. All individual records were anonymized by the data provider prior to public release.

Identifiants

pubmed: 30703096
doi: 10.1371/journal.pntd.0007085
pii: PNTD-D-18-00688
pmc: PMC6377149
doi:

Substances chimiques

Anthelmintics 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0007085

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Indian J Pediatr. 2001 Sep;68(9):823-7
pubmed: 11669028
BMJ. 2001 Dec 15;323(7326):1389-93
pubmed: 11744561
East Afr Med J. 2001 Jun;78(6):283-6
pubmed: 12002102
Proc Biol Sci. 1992 Feb 22;247(1319):77-81
pubmed: 1349184
Trop Med Int Health. 2005 Nov;10(11):1187-9
pubmed: 16262745
Lancet. 2006 May 6;367(9521):1521-32
pubmed: 16679166
BMJ. 2006 Jul 15;333(7559):122
pubmed: 16790460
Ann Trop Med Parasitol. 1991 Oct;85(5):551-68
pubmed: 1809249
PLoS Negl Trop Dis. 2008 Mar 26;2(3):e126
pubmed: 18365031
BMJ. 1990 Nov 17;301(6761):1111
pubmed: 2252919
Annu Rev Econom. 2010 Sep;2:283-310
pubmed: 24147187
Parasit Vectors. 2014 Jan 21;7:37
pubmed: 24447578
Food Nutr Bull. 2014 Mar;35(1):92-104
pubmed: 24791583
J Econ Perspect. 2011 Summer;25(3):153-172
pubmed: 25152565
J Health Econ. 2015 Jan;39:17-30
pubmed: 25461896
Cochrane Database Syst Rev. 2015 Jul 23;(7):CD000371
pubmed: 26202783
Int J Epidemiol. 2015 Oct;44(5):1572-80
pubmed: 26203169
Eur J Epidemiol. 2016 Apr;31(4):337-50
pubmed: 27209009
Lancet Infect Dis. 2016 Sep;16(9):1065-1075
pubmed: 27286968
Q J Econ. 2016 Nov;131(4):1637-1680
pubmed: 27818531
Lancet Glob Health. 2017 Jan;5(1):e2-e3
pubmed: 27955773
Am J Trop Med Hyg. 2017 Jun;96(6):1478-1489
pubmed: 28093533
Int J Epidemiol. 2016 Dec 1;45(6):2140-2153
pubmed: 28161712
Int J Epidemiol. 2016 Dec 1;45(6):2166-2168
pubmed: 28161715
Int J Epidemiol. 2016 Dec 1;45(6):2156-2158
pubmed: 28161718
Int J Epidemiol. 2016 Dec 1;45(6):2163-2165
pubmed: 28161719
Annu Rev Nutr. 2017 Aug 21;37:447-476
pubmed: 28564554
Am Econ Rev. 2009 Jun;99(3):1006-26
pubmed: 29508969
BMJ. 1995 Aug 19;311(7003):485
pubmed: 7647644
Parasitology. 1995 May;110 ( Pt 4):457-64
pubmed: 7753585

Auteurs

Kevin Croke (K)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Rifat Atun (R)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH